Conference
Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP).
Abstract
27
Background: The considerable interest in short UHR 5-12 fractions(fr) in management of CaP is based on potential radiobiological advantages, patient convenience & resource allocation benefits. Prior to comparison with standard RT regimens (SRTR), a study was undertaken whose primary objective was to demonstrate that 1-year health-related quality of life (HRQOL) for at least one UHR arm was not significantly lower than …
Authors
Lukka H; Pugh SL; Bruner D; Bahary J-P; Lawton CA; Efstathiou JA; Kudchadker R; Ponsky LE; Seaward SA; Dayes IS
Volume
34
Pagination
pp. 27-27
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
January 10, 2016
DOI
10.1200/jco.2016.34.2_suppl.27
Conference proceedings
Journal of Clinical Oncology
Issue
2_suppl
ISSN
0732-183X